Dalbavancin is a lipoglycopeptide antibiotic with a prolonged half-life. A phase 1 study assessed dalbavancin levels in epithelial lining fluid (ELF) in 35 healthy adults using ELF bronchial microsampling up to 168 h after administration of 1,500 mg dalbavancin. The penetration of dalbavancin into ELF was 36%. ELF levels of dalbavancin exceeded the MIC 90 s of Streptococcus pneumoniae and Staphylococcus aureus for ≥7 days. ABSTRACT Dalbavancin is a lipoglycopeptide antibiotic with a prolonged half-life. A phase 1 study assessed dalbavancin levels in epithelial lining fluid (ELF) in 35 healthy adults using ELF bronchial microsampling up to 168 h after administration of 1,500 mg dalbavancin. The penetration of dalbavancin into ELF was 36%. ELF levels of dalbavancin exceeded the MIC 90 s of Streptococcus pneumoniae and Staphylococcus aureus for ≥7 days.
【저자키워드】 Pneumonia, pharmacokinetics, Pharmacodynamics, dalbavancin, lung epithelial lining fluid,